Drugs / PEA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03651726 | Aug 2018 → Nov 2019 | Tourette syndrome | Neurothera Labs Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03651726 ↗ |
| Route | Oral | “taken orally once daily” NCT03651726 ↗ |